↓ Skip to main content

Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy

Overview of attention for article published in Clinical Pharmacology & Therapeutics, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
1 policy source
twitter
9 X users

Citations

dimensions_citation
152 Dimensions

Readers on

mendeley
111 Mendeley
Title
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy
Published in
Clinical Pharmacology & Therapeutics, April 2019
DOI 10.1002/cpt.1409
Pubmed ID
Authors

Jacob T. Brown, Jeffrey R. Bishop, Katrin Sangkuhl, Erika L. Nurmi, Daniel J. Mueller, Jean C. Dinh, Andrea Gaedigk, Teri E. Klein, Kelly E. Caudle, James T. McCracken, Jose de Leon, J. Steven Leeder

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 15%
Student > Bachelor 13 12%
Student > Master 10 9%
Other 9 8%
Student > Doctoral Student 8 7%
Other 14 13%
Unknown 40 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 17%
Pharmacology, Toxicology and Pharmaceutical Science 19 17%
Medicine and Dentistry 14 13%
Agricultural and Biological Sciences 5 5%
Economics, Econometrics and Finance 2 2%
Other 10 9%
Unknown 42 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#1,586,756
of 25,401,784 outputs
Outputs from Clinical Pharmacology & Therapeutics
#222
of 4,504 outputs
Outputs of similar age
#35,661
of 366,202 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#10
of 60 outputs
Altmetric has tracked 25,401,784 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,504 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,202 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.